Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00732082
Recruitment Status : Terminated (Company manufacturing study drug was unable to continue production.)
First Posted : August 11, 2008
Last Update Posted : June 12, 2013
Information provided by (Responsible Party):
Washington University School of Medicine

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 2010
Actual Study Completion Date : September 2012
Immutep. 2006. ImmuFact IMP321 Product Information Brochure.
Co, E.L.a., Gemcitabine Product Info. 2003.
Series, M.H., 2003. MICROMEDEX, Greenwood Village, Colorado